Date: January 28, 2022
Time: 13:00 to 19:00 CET
In continuation to the scientific discussions on COVID-19 vaccines research, WHO R&D Blueprint is organizing a consultation to identify vaccine research priorities to facilitate further contributions of vaccines to achieve improved control of the pandemic everywhere.
During this forthcoming consultation global experts will review the available evidence, enumerate knowledge gaps, and outline research priorities related to a pan-sarbecovirus vaccine. The objectives of the meeting are to:
- Review scientific advances and development approaches to enable the development of a pan-sarbecovirus vaccine
- Provide an overview of various candidate vaccines under development
- Outline novel approaches for evaluation of pan-sarbecovirus vaccines, including in the context of the different variants of concern
Download Agenda
PRESENTATIONS:
Session 1. Is there a need for a pan-sarbecovirus vaccine?
Session 2. What are promising approaches to a pan–sarbecovirus vaccine?
Session 3. How could pan–sarbecovirus vaccines be evaluated to down–select among candidates and assure that they will likely protect against current and future variants?
Vaccine Developers: How can pan–sarbecovirus vaccines be rapidly developed and evaluated?
Overall conclusions, knowledge gaps and research priorities
